Compare INTT & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTT | BNR |
|---|---|---|
| Founded | 1981 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.9M | 233.7M |
| IPO Year | 1997 | 2020 |
| Metric | INTT | BNR |
|---|---|---|
| Price | $7.28 | $20.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 33.5K | ★ 74.0K |
| Earning Date | 11-05-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $117,606,000.00 | $75,749,382.00 |
| Revenue This Year | N/A | $136.32 |
| Revenue Next Year | $9.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.56 |
| 52 Week Low | $5.24 | $2.18 |
| 52 Week High | $9.77 | $23.59 |
| Indicator | INTT | BNR |
|---|---|---|
| Relative Strength Index (RSI) | 43.21 | 60.96 |
| Support Level | $7.07 | $15.71 |
| Resistance Level | $8.00 | $18.42 |
| Average True Range (ATR) | 0.41 | 2.16 |
| MACD | -0.04 | -0.18 |
| Stochastic Oscillator | 21.19 | 63.02 |
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.